1. 3-Year Efficacy and Durability of Simplification to Single Tablet Regimens: A Comparison between Co-Formulated Efavirenz/Emtricitabine/Tenofovir and Rilpivirine/Emtricitabine/Tenofovir. Issue 2 (February 2018) Authors: Gagliardini, Roberta; Bandera, Alessandra; Zaccarelli, Mauro; Sterrantino, Gaetana; Latini, Alessandra; D'Avino, Alessandro; Lapadula, Giuseppe; Antinori, Andrea; Cauda, Roberto; De Luca, Andrea; Gori, Andrea; Giambenedetto, Simona; Fabbiani, Massimiliano Journal: Antiviral therapy Issue: Volume 23:Issue 2(2018) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 96-Week Resistance Analyses of Rilpivirine in Treatment-Naive, HIV-1-Infected Adults from the Echo and Thrive Phase Iii Trials. Issue 8 (November 2013) Authors: Rimsky, Laurence; Van Eygen, Veerle; Hoogstoel, Annemie; Stevens, Marita; Boven, Katia; Picchio, Gaston; Vingerhoets, Johan Journal: Antiviral therapy Issue: Volume 18:Issue 8(2013) Page Start: 967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine, plus Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: Assert Study. Issue 7 (October 2013) Authors: Moyle, Graeme J; Stellbrink, Hans-Jürgen; Compston, Juliet; Orkin, Chloe; Arribas, José R; Domingo, Pere; Granier, Catherine; Pearce, Helen; Sedani, Sangeeta; Gartland, Martin Journal: Antiviral therapy Issue: Volume 18:Issue 7(2013) Page Start: 905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive chronic hepatitis B patients. Issue 6 (November 2021) Authors: Fang, Yu-Qing; Xu, Xiao-Yan; Hou, Feng-Qin; Jia, Wei Journal: Antiviral therapy Issue: Volume 26:Issue 6/8(2021) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Boceprevir Failure in a Patient Infected with HCV Genotype 1G: Importance and Limitations of Virus Genotyping Prior to HCV Protease-Inhibitor-Based Therapy. Issue 4 (May 2013) Authors: Cento, Valeria; Landonio, Simona; De Luca, Francesca; Maio, Velia C Di; Micheli, Valeria; Mirabelli, Carmen; Niero, Fosca; Magni, Carlo; Rizzardini, Giuliano; Perno, Carlo F; Ceccherini-Silberstein, Francesca Journal: Antiviral therapy Issue: Volume 18:Issue 4(2013) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Case of a Probable drug Interaction between Lurasidone and Atazanavir-Based Antiretroviral Therapy. Issue 8 (November 2016) Authors: Naccarato, Mark; Hall, Elise; Wai, Alan; Ostrowski, Mario; Carvalhal, Adriana Journal: Antiviral therapy Issue: Volume 21:Issue 8(2016) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Case Study of Chewed Truvada® for PrEP Maintaining Protective drug Levels as Measured by a Novel Urine Tenofovir Assay. Issue 7 (October 2017) Authors: Lalley-Chareczko, Linden; Clark, Devon; Zuppa, Athena F; Moorthy, Ganesh; Conyngham, Caitlin; Mounzer, Karam; Koenig, Helen Journal: Antiviral therapy Issue: Volume 22:Issue 7(2017) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized Adults. Issue 5 (July 2013) Authors: Ison, Michael G; Hui, David S; Clezy, Kate; O'Neil, Brian J; Flynt, Amy; Collis, Philip J; Simon, Thomas J; Alexander, W James Journal: Antiviral therapy Issue: Volume 18:Issue 5(2013) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients. Issue 1 (January 2019) Authors: Ciccullo, Arturo; Baldin, Gianmaria; Capetti, Amedeo; Rusconi, Stefano; Sterrantino, Gaetana; d'Ettorre, Gabriella; Colafigli, Manuela; Modica, Sara; Lagi, Filippo; Giacomelli, Andrea; Cossu, Maria Vittoria; Restelli, Sibilla; De Luca, Andrea; Di Giambenedetto, Simona Journal: Antiviral therapy Issue: Volume 24:Issue 1(2019) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Comparison of Virological Suppression and Rebound between Indigenous and Non-Indigenous Persons Initiating Combination Antiretroviral Therapy in a Multisite Cohort of Individuals Living with HIV in Canada. Issue 4 (May 2017) Authors: Benoit, Anita C; Younger, Jaime; Beaver, Kerrigan; Jackson, Randy; Loutfy, Mona; Masching, Renée; Nobis, Tony; Nowgesic, Earl; O'Brien-Teengs, Doe; Whitebird, Wanda; Zoccole, Art; Hull, Mark; Jaworsky, Denise; Rachlis, Anita; Rourke, Sean; Burchell, Ann N; Cooper, Curtis; Hogg, Robert; Klein, Mar... Journal: Antiviral therapy Issue: Volume 22:Issue 4(2017) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗